Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 163

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 163
---
| 12 | Includes                                                                                                       
 31,250 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant. |

| 13 | Includes                                                                                                       
 781,250 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant |

| 14 | Includes                                                                                                      
 46,875 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant |

| 15 | Includes                                                                                                       
 36,156 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant. |

| 16 | Includes                                                                                                        
 158,203 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant. |

| 17 | Includes                                                                                                       
 35,116 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant. |

| 18 | Includes                                                                                                      
 125,00 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant |

| 19 | Includes                                                                                                       
 62,500 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant. |

| 20 | Includes                                                                                                        
 375,000 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant. |

| 21 | Includes                                                                                                        
 312,500 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant. |

| 22 | Includes                                                                                                       
 250,000 shares the selling stockholder has the right to acquire through the exercise of a common stock warrant |

| 23 | Includes                                                                                                                            
 690,000 shares the selling stockholder has the right to acquire through the exercise of an options issued under the Company’s stock 
 option plan.                                                                                                                        |

| 24 | David                                                                                                                                 
 Safrin has the power to vote or dispose of the securities held of record by the selling stockholder and may be deemed to beneficially 
 own those securities. David Safrin disclaims beneficial ownership with respect to such shares, except to the extent of his pecuniary  
 interest therein                                                                                                                      |

Material Relationships with Selling Stockholders.

Other than as disclosed above, none of the Selling Stockholders has had a material relationship with us or any of our affiliates other than as a stockholder at any time within the past three years.

<div align='center'>Alt-3

[RES